Press Release

DCAT Member Company Announcement Forum: Major News Impacting the Pharma Mfg Value Chain

Robbinsville, NJ, USA February 19, 2019 -- The Drug, Chemical & Associated Technologies Association (DCAT) is pleased to announce the DCAT member companies that will be presenting at the DCAT Member Company Announcement Forum on Monday, March, 18, 2019 from 9:30 am to 11:30 am at the Lotte New York Palace, Villard Ballroom. This complimentary event is open to all DCAT Week attendees and the industry trade press. Registration is required at www.DCATWeek.org.

The DCAT Member Company Announcement Forum is a fast-paced, exclusive venue for senior executives at DCAT member companies to present brief announcements on major news from their companies impacting the pharmaceutical manufacturing value chain, such as mergers and acquisitions (including post-M&A integration) and significant manufacturing expansions.

DCAT member companies presenting at this year’s event are:

AbbVie

BSP Pharmaceuticals SpA

Cambrex Corporation

Catalent Pharma Solutions

Cerbios-Pharma SA

Lonza AG

SCHOTT AG

Selkirk Pharma

SEQENS

Servier CDMO

Thermo Fisher Scientific

“DCAT Week is the perfect venue for major announcements because the right people are there—92% of attendees are high-level decision makers, with one in four attendees being C-Suite executives,” said DCAT Executive Director Margaret Timony. “DCAT started the Forum four years ago as a high-profile platform for our member companies to take advantage of this important audience. Due to time limitations, not every member company that applies gets podium time. An Oversight Task Force composed of DCAT volunteers evaluates the applications and assigns podium time.”

About DCAT Week

DCAT Week (March 18-21, 2019), which is hosted by the DCAT organization each March in New York City, is the premier global business development event for companies engaged in pharmaceutical development and manufacturing and related industries. The event attracts thousands of high-level global decision makers, representing the full spectrum of the pharma value chain, for strategic meetings, networking opportunities and industry education programs. www.DCATWeek.org

About DCAT

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing. With over 400 corporate members, DCAT is headquartered in Robbinsville, New Jersey.

Contact

Drug, Chemical & Associated Technologies Association

Erin Sanders, 609-208-1888 x7001

Senior Communications & Technology Specialist

esanders@dcat.org

###

Drug, Chemical & Associated
Technologies Association (DCAT)
Global Headquarters
One Union St., Suite 208
Robbinsville, NJ 08691
Phone: +1-609-208-1888
Toll free: +1-800-640-DCAT (3228)
International: +41 61 510 05 00
Fax: +1-609-208-0599
info@dcat.org

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting biopharmaceutical/pharmaceutical development and manufacturing.